Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma

Abstract Objective: The average age of patients with vulvar squamous cell carcinoma (SCC) has been reported to have declined. Human papilloma virus (HPV)-related lesions have been shown to be associated with the expression of the immunohistochemical (IHC) marker p16. Non-HPV-related tumors have bee...

Full description

Saved in:
Bibliographic Details
Main Authors: Lorenza Bridi Todeschini, Rita de Cássia Sant’Anna Alves, Adriana Vial Roehe
Format: Article
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2025-01-01
Series:Revista Brasileira de Ginecologia e Obstetrícia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032024000100263&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592573133225984
author Lorenza Bridi Todeschini
Rita de Cássia Sant’Anna Alves
Adriana Vial Roehe
author_facet Lorenza Bridi Todeschini
Rita de Cássia Sant’Anna Alves
Adriana Vial Roehe
author_sort Lorenza Bridi Todeschini
collection DOAJ
description Abstract Objective: The average age of patients with vulvar squamous cell carcinoma (SCC) has been reported to have declined. Human papilloma virus (HPV)-related lesions have been shown to be associated with the expression of the immunohistochemical (IHC) marker p16. Non-HPV-related tumors have been characterized by p53 abnormal expression and PDL1 expression. We aimed to evaluate the correlation between these markers and vulvar SCC and to relate it to the clinical and pathological characteristics. Methods: Histopathologic assessments and IHC analyses of p16, p53, and PDL1 were performed in 41 samples of vulvar SCC collected between 2016 and 2021. The data were correlated with clinical and pathological characteristics of the patients. Results: The mean age of the patients was 72.1 years. Positive p16 and PDL1 staining was detected in 24.4% and 17.1% of the samples, respectively. p53 expression was negative in 19.5% of the samples, whereas it was overexpressed in 24.4%. p16-positive tumors showed a smaller depth of invasion (DOI) (p = 0.014), while tumors with p53 abnormal expression showed greater DOI (p = 0.041). PDL1 expression was correlated with increased number of inflammatory cells (p = 0.055). In addition, lesions with lymphovascular space invasion were p16-negative. Conclusion: In our sample, regarding to the SCC incidence the patients’ mean age did not change. The expression of p16 was inversely correlated with p53 results. Tumors with p53 abnormal expression and absence of p16 showed a greater DOI. Our data suggest an association between PDL1 expression and increased inflammatory infiltrates in vulvar SCC.
format Article
id doaj-art-72b881cb9c3f43bc8d1c76ddcc38e035
institution Kabale University
issn 0100-7203
language English
publishDate 2025-01-01
publisher Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
record_format Article
series Revista Brasileira de Ginecologia e Obstetrícia
spelling doaj-art-72b881cb9c3f43bc8d1c76ddcc38e0352025-01-21T07:35:53ZengFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia0100-72032025-01-014610.61622/rbgo/2024rbgo91Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinomaLorenza Bridi Todeschinihttps://orcid.org/0000-0002-9593-912XRita de Cássia Sant’Anna Alveshttps://orcid.org/0000-0003-1204-4978Adriana Vial Roehehttps://orcid.org/0000-0002-6294-7342Abstract Objective: The average age of patients with vulvar squamous cell carcinoma (SCC) has been reported to have declined. Human papilloma virus (HPV)-related lesions have been shown to be associated with the expression of the immunohistochemical (IHC) marker p16. Non-HPV-related tumors have been characterized by p53 abnormal expression and PDL1 expression. We aimed to evaluate the correlation between these markers and vulvar SCC and to relate it to the clinical and pathological characteristics. Methods: Histopathologic assessments and IHC analyses of p16, p53, and PDL1 were performed in 41 samples of vulvar SCC collected between 2016 and 2021. The data were correlated with clinical and pathological characteristics of the patients. Results: The mean age of the patients was 72.1 years. Positive p16 and PDL1 staining was detected in 24.4% and 17.1% of the samples, respectively. p53 expression was negative in 19.5% of the samples, whereas it was overexpressed in 24.4%. p16-positive tumors showed a smaller depth of invasion (DOI) (p = 0.014), while tumors with p53 abnormal expression showed greater DOI (p = 0.041). PDL1 expression was correlated with increased number of inflammatory cells (p = 0.055). In addition, lesions with lymphovascular space invasion were p16-negative. Conclusion: In our sample, regarding to the SCC incidence the patients’ mean age did not change. The expression of p16 was inversely correlated with p53 results. Tumors with p53 abnormal expression and absence of p16 showed a greater DOI. Our data suggest an association between PDL1 expression and increased inflammatory infiltrates in vulvar SCC.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032024000100263&lng=en&tlng=enVulvar squamous cell carcinomaImmunohistochemistryp16p53PDL1
spellingShingle Lorenza Bridi Todeschini
Rita de Cássia Sant’Anna Alves
Adriana Vial Roehe
Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
Revista Brasileira de Ginecologia e Obstetrícia
Vulvar squamous cell carcinoma
Immunohistochemistry
p16
p53
PDL1
title Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
title_full Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
title_fullStr Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
title_full_unstemmed Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
title_short Clinical, histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
title_sort clinical histopathological and immunohistochemical analysis of vulvar squamous cell carcinoma
topic Vulvar squamous cell carcinoma
Immunohistochemistry
p16
p53
PDL1
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032024000100263&lng=en&tlng=en
work_keys_str_mv AT lorenzabriditodeschini clinicalhistopathologicalandimmunohistochemicalanalysisofvulvarsquamouscellcarcinoma
AT ritadecassiasantannaalves clinicalhistopathologicalandimmunohistochemicalanalysisofvulvarsquamouscellcarcinoma
AT adrianavialroehe clinicalhistopathologicalandimmunohistochemicalanalysisofvulvarsquamouscellcarcinoma